Recombinant IL17A, IL17F (Bimekizumab Biosimilar) antibody

Catalog No. ABIN7488037

The Mammalian Cells Monoclonal anti-IL17A, IL17F (Bimekizumab Biosimilar) antibody (ABIN7488037) specifically detects IL17A, IL17F (Bimekizumab Biosimilar) in ELISA and WB. The antibody is reactive with Human samples.

Quick Overview for Recombinant IL17A, IL17F (Bimekizumab Biosimilar) antibody (ABIN7488037)

Target: IL17A, IL17F (Bimekizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL17A, IL17F (Bimekizumab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-IL17A, IL17F (Bimekizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IL17A, IL17F (Bimekizumab Biosimilar)

Target: IL17A, IL17F (Bimekizumab Biosimilar)

Sub Type: Cocktail

Target Type: Biosimilar

Background: CDP4940